: The Health Ministry has granted a conditional registration approval for Veklury for the emergency treatment of Covid-19.
“The MOH wishes to inform that this conditional registration approval requires that information on the quality, safety and effectiveness of antivirus products be monitored and evaluated continuously by the National Pharmaceutical Regulatory Division based on the latest data from time to time. Veklury is indicated for Covid-19 treatment in adults and pediatric patients, aged 12 and older and weighing at least 40 kilogrammes with positive SARS-CoV-2 viral test results, hospitalised, or not hospitalised and have mild-to-moderate Covid-19 and are at high risk for progression to severe Covid-19 including hospitalisation or death.
The NPRA evaluation on the quality, safety and efficacy data of TELDY products was found to be satisfactory for use on its own as a complete regimen for the treatment of HIV-1 infection among adults and adolescents aged 12 years and above who weigh 40 kg or more,“ he said.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: msianinsight - 🏆 8. / 63 Read more »
Source: malaymail - 🏆 1. / 86 Read more »
Source: malaymail - 🏆 1. / 86 Read more »
Source: msianinsight - 🏆 8. / 63 Read more »
Source: staronline - 🏆 4. / 75 Read more »
Source: msianinsight - 🏆 8. / 63 Read more »